<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Protein aggregation in Huntington's disease - Health AI Hub</title>
    <meta name="description" content="This paper investigates protein aggregation mechanisms in Huntington's disease (HD), where an expanded polyglutamine (polyQ) tract in huntingtin causes a toxic ">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Protein aggregation in Huntington's disease</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.04174v1" target="_blank">2511.04174v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-06
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Guylaine Hoffner, Philippe Djian
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.BM, q-bio.NC
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.04174v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2511.04174v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper investigates protein aggregation mechanisms in Huntington's disease (HD), where an expanded polyglutamine (polyQ) tract in huntingtin causes a toxic gain of function leading to neuronal death. It outlines two proposed aggregation mechanisms ‚Äì hydrogen bonding (polar-zipper) and transglutaminase-catalyzed covalent cross-linking ‚Äì noting that while cell culture models show aggregates primarily stabilized by hydrogen bonds, the nature of these bonds in the brains of HD patients remains unknown and is critical for informing therapeutic strategies.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Understanding the specific molecular forces stabilizing toxic protein aggregates in Huntington's disease is paramount for designing targeted therapies capable of disrupting or preventing their formation, thereby potentially halting or reversing neurodegeneration and disease progression.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>Not applicable based on the abstract content, as the paper does not discuss AI applications. However, the fundamental understanding of disease mechanisms is crucial for future AI-driven drug discovery and therapeutic development in neurodegenerative diseases.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Expanded polyglutamine (polyQ) in the huntingtin protein leads to a toxic gain of function, characteristic of Huntington's disease (HD).</li>
                    
                    <li>Protein aggregation resulting from this toxic gain of function is hypothesized to be the primary cause of neuronal death in HD.</li>
                    
                    <li>Two main molecular mechanisms for protein aggregation are proposed: hydrogen bonding through polar-zipper formation and covalent bonding catalyzed by transglutaminase.</li>
                    
                    <li>In cell culture models of HD, protein aggregates are predominantly stabilized by hydrogen bonds, though covalent bonds are also considered likely to contribute.</li>
                    
                    <li>Crucially, the specific nature of the bonds stabilizing protein aggregates within the brains of human HD patients is currently unknown.</li>
                    
                    <li>Identifying the precise type of bond stabilizing these aggregates in vivo is deemed one of the most important questions, as it will dictate the most effective therapeutic approaches for HD.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The paper discusses findings primarily derived from cell culture models of Huntington's disease. It also conceptualizes proposed molecular mechanisms (hydrogen bonding, covalent bonding) and highlights critical unknowns in human brain pathology.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>Expanded polyglutamine tracts induce toxic protein aggregation, a likely cause of neuronal death in HD. Aggregation is proposed to occur via hydrogen bonding (polar-zipper) and/or transglutaminase-catalyzed covalent cross-linking. Cell culture models demonstrate aggregates stabilized predominantly by hydrogen bonds, with potential covalent contributions.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>Elucidating whether aggregates in human HD brains are stabilized by hydrogen or covalent bonds will directly guide the development of specific therapeutic agents. For instance, inhibitors targeting transglutaminase would be effective against covalent bonds, while strategies disrupting hydrogen bonds would target polar-zippers, leading to more precise and effective drug development.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>A significant limitation noted is the complete lack of knowledge regarding the nature of bonds stabilizing protein aggregates directly within the brains of Huntington's disease patients, implying that current understanding relies heavily on in vitro/cell culture models that may not fully recapitulate in vivo conditions.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Future research must prioritize determining the specific type of bonds (hydrogen versus covalent) that stabilize protein aggregates in the brains of patients with Huntington's disease, as this knowledge is fundamental for designing and implementing effective, mechanism-specific therapeutic interventions.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neurology</span>
                    
                    <span class="tag">Neurodegenerative Diseases</span>
                    
                    <span class="tag">Molecular Medicine</span>
                    
                    <span class="tag">Pharmacology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Huntington's disease</span>
                    
                    <span class="tag tag-keyword">protein aggregation</span>
                    
                    <span class="tag tag-keyword">polyglutamine</span>
                    
                    <span class="tag tag-keyword">neuronal death</span>
                    
                    <span class="tag tag-keyword">hydrogen bonding</span>
                    
                    <span class="tag tag-keyword">covalent bonding</span>
                    
                    <span class="tag tag-keyword">transglutaminase</span>
                    
                    <span class="tag tag-keyword">therapeutic targets</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">The presence of an expanded polyglutamine produces a toxic gain of function
in huntingtin. Protein aggregation resulting from this gain of function is
likely to be the cause of neuronal death. Two main mechanisms of aggregation
have been proposed: hydrogen bonding by polar-zipper formation and covalent
bonding by transglutaminase-catalyzed cross-linking. In cell culture models of
Huntington's disease, aggregates are mostly stabilized by hydrogen bonds, but
covalent bonds are also likely to occur. Nothing is known about the nature of
the bonds that stabilize the aggregates in the brain of patients with
Huntington's disease. It seems that the nature of the bond stabilizing the
aggregates is one of the most important questions, as the answer would
condition the therapeutic approach to Huntington's disease.</p>
            </section>

            

            
            <section class="paper-section">
                <h2>Journal Reference</h2>
                <p>Biochimie, 2002, 84 (4), pp.273-278</p>
            </section>
            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>